ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2836

Development of a Health Index in Patients With Ankylosing Spondylitis (ASAS HI) – Final Result of a Global Initiative Based On the International Classification of Functioning, Disability and Health (ICF) Guided By Assesment of Spondyloarthritis International Society (ASAS)

Uta Kiltz1, Désiréé van der Heijde2, Annelies Boonen3, Alarcos Cieza4, Gerold Stucki5, Muhammad Asim Khan6, Walter P. Maksymowych7, Helena Marzo-Ortega8, John D. Reveille9, Simon Stebbings10, Cristina Bostan11 and Juergen Braun1, 1Rheumazentrum Ruhrgebiet, Herne, Germany, 2Leiden University Medical Center, Leiden, Netherlands, 3Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center, Maastricht, Netherlands, 4Department of Psychology, University Southampton, Southampton, United Kingdom, 5University of Lucerne, Lucerne, Switzerland, 6Medicine/ Rheumatology, Case Western Reserve University Hospital, Cleveland, OH, 7Medicine/Rheumatic Dis Unit, University of Alberta, Edmonton, AB, Canada, 8Leeds Musculoskeletal Biomedical Research Unit and University of Leeds, Leeds, United Kingdom, 9Division of Rheumatology, Univ of Texas Health Science Center at Houston, Houston, TX, 10Dunedin School of Medicine, University of Otago, Dunedin, New Zealand, 11Paraplegic Research Unit, Nottwil, Switzerland

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Ankylosing spondylitis (AS), functional status and spondylarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Spondylarthropathies and Psoriatic Arthritis: Clinical Aspects and Treatment: Clinical and Imaging Aspects of Axial Spondyloarthritis

Session Type: Abstract Submissions (ACR)

Background/Purpose:

The impact of ankylosing spondylitis (AS) on a patient’s life can be considerable. Patients suffer from pain, stiffness and fatigue, are limited in their activities, and restricted in social participation. The International Classification of Functioning, Disability and Health (ICF) is a model to systematically classify and describe functioning, disability, and health in human beings. However no ICF-based patient-reported outcome measure has been developed. the objective is to develop a measure to assess health in patients with AS, the ASAS (Assessments of SpondyloArthritis international Society (ASAS)) Health Index, based on the Comprehensive ICF Core Set for AS.

Methods:

Development has been performed in five phases.

Table 1: Phases of development for the ASAS Health Index

 

Phase

Objectives

Methods

Ia

Preparatory

Development of a pool of items representing the categories of the Comprehensive ICF Core Set for AS

Linkage of various assessment tools for functioning and health to ICF categories

Ib

Patient meeting

Patient preference and weighting of the items per ICF category

Relative weight to each item, patients distributed 100 points per ICF category.

II

1st postal patient survey

Item reduction (within and across ICF categories)

Factor Analysis, Rasch Analysis, Spearman rank correlation coefficient

III

Expert consultation

Agreement on item reduction

Nominal Consensus Process

IV

2nd postal patient survey

Validation of the draft version and further item reduction

Testing psychometric properties

Rasch Analysis

V

Consensus Meeting

Agreement on a final version

Nominal Consensus Process

Results:

Phase 1: The item pool contained 251 items in 44 categories. Phase 2 was performed based on data collected along an international cross sectional study among 1915 AS patients (mean age 51.2±3.6, 53% male, BASDAI 5.5±2.4) in 4 continents. For 82 items of the functioning part a unidimensional scale, fit to the Rasch model and absence of Differential Item Function (DIF) could be confirmed. Phase 3: An expert committee selected 50 functioning items using predefined selection criteria. Phase 4: An international cross sectional study with 628 AS patients (mean age 48.5±14.2, 51.6% male, BASDAI 5.6±2.3) was conducted in 4 continents. Misfit was identified in 4 items and DIF in 15 items. More than 50% of the items showed a residual correlation between each other above a value of 0.2 in the initial round. Phase 5: Based on results of the analyses in step 4, the consensus members agreed on 17 final items. In the 17 items fit to the model, no residual correlation and absence of constant DIF could be confirmed with a Person-Separation Index of 0.82. The item location has been shown to be 0.00 ± 1.84 with a fit residual of 0.06 ± 1.24 and the person location has been shown to be 0.01 ± 1.80 with a fit residual of -0.30 ± 0.67. The chi-square probability was 0.73.

Conclusion: The ASAS HI measure contains 17 dichotomous items addressing categories of pain, emotional functions, sleep, sexual functions, mobility, self-care, community life and employment. In covering much of the ICF Core Set for AS, these items represent a whole range of abilities of patients with AS. The questionnaire will be translated and further tested for sensitivity to change. ASAS HI can be used in clinical trials and clinical practice as a new composite index that captures relevant information on the health status of the patients.


Disclosure:

U. Kiltz,
None;

D. van der Heijde,
None;

A. Boonen,
None;

A. Cieza,
None;

G. Stucki,
None;

M. A. Khan,
None;

W. P. Maksymowych,
None;

H. Marzo-Ortega,
None;

J. D. Reveille,
None;

S. Stebbings,
None;

C. Bostan,
None;

J. Braun,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/development-of-a-health-index-in-patients-with-ankylosing-spondylitis-asas-hi-final-result-of-a-global-initiative-based-on-the-international-classification-of-functioning-disability-and-h/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology